Introduction {#s1}
============

Tongue squamous cell carcinoma (SCC) is the most common oral cavity malignancy ([@B1], [@B2]), its prognosis has not improved significantly despite advances in diagnosis and treatment, neck lymph node metastasis is one of the most important prognostic factors ([@B3], [@B4]), but unfortunately these positive lymph nodes are usually occult or subclinical at the initial treatment in early stage tongue SCC. Owing to a wide range of occult metastasis rate ([@B5], [@B6]), either elective neck dissection (END) or the watchful waiting policy has been the favored treatment for cT1-2N0 tongue SCC ([@B7], [@B8]). Investigators favoring for END comment that END allows more accurate disease stage and decision of the need for adjuvant therapies, and resection of metastatic lymph nodes could potentially reduce the recurrence risk ([@B9], [@B10]), however, the main concern according to the traditional watchful waiting policy is the associated surgical complication including shoulder dysfunction and over-treatment for those patients having no pathologic metastases ([@B11]). Considering there is no accurate diagnostic procedure for staging the neck preoperatively, the elective management of the neck in cT1-2N0 tongue SCC has been the subject of much debate during the past three decades and continues to be controversial.

Lingual lymph nodes (LLNs) were firstly introduced by Rouviere et al. ([@B12]). These authors have divided LLNs into two groups: the lateral lingual nodes are lateral to the genioglossus or the hyoglossus muscles, and the median lingual node resides between the medial side of the genioglossus muscle and the lingual septum ([@B12], [@B13]). A number of researchers have reported the phenomenon of LLN metastasis in primary or recurrent oral SCC by cases reports ([@B14]--[@B22]), but whether there is significant association between LLN metastasis and occult lymph node metastasis as well as whether there is prognostic value of LLN metastasis in early stage tongue SCC remain unknown. Therefore, the current study aimed to clarify these questions.

Methods {#s2}
=======

The Zhengzhou University institutional research committee approved our study, and all participants provided written informed consent for medical research prior to enrollment in the study. All experiments were performed in accordance with relevant guidelines and regulations.

From January 2010 to December 2018, patients with primary cT1-2N0 tongue SCC according to the 7th AJCC classification were prospectively investigated. The only inclusion criteria was that patients underwent surgical treatment for primary cancer disease; patients who lost their visits were excluded for analysis. Information including age, sex, adverse pathologic characteristics, and follow-up of enrolled patients was collected and analyzed. All patients had underwent a neck dissection. Drinkers were defined as those who consumed at least one alcoholic drink per day for at least 1 year ([@B2], [@B3]), smokers were defined as those smoked on a daily basis or had quit smoking for less than 5 years ([@B2], [@B3]). cT1-2 was defined as a maximum diameter of tumors \<2 cm or a diameter ranging from 2 to 4 cm, patients were considered to have cN0 disease if they had no evidence of nodal metastasis on clinical examination, ultrasound, or radiographic imaging ([@B23], [@B24]).

All pathologic sections were reviewed by at least two pathologists, and perineural invasion was considered to be present if tumor cells were identified within the perineural space and/or nerve bundle; lymphovascular infiltration was positive if tumor cells were noted within the lymphovascular channels ([@B23]). The pathologic depth of invasion (DOI) was measured from the level of the adjacent normal mucosa to the deepest point of tumor infiltration, regardless of the presence or absence of ulceration ([@B24]).

All patients underwent radical primary tumor excision with a minimum margin of 1 cm, the muscle of the mouth floor was preserved in highest measure, the adipose tissue in the mouth floor including the sublingual gland was separated from the primary tumor, and then dissected for any possible lymph nodes ([Figure 1](#F1){ref-type="fig"}) for postoperative pathology analysis independently, END (levelI-III) was routinely performed for tongue SCC patients with the exception of very early-stage disease in our cancer center. Indication for adjuvant treatment included perineural invasion, lymphovascular invasion, positive margin, and cervical lymph node metastasis. All patients were regularly followed every 3 months within the first 2 years after the operation and every 6 months within the third to fifth year after the operation. If there was any doubt regarding disease recurrence, active interference was performed. ([@B25]).

![Lingual lymph node (white row).](fonc-10-00471-g0001){#F1}

The association between neck occult metastasis and clinical pathologic variables was firstly evaluated by the Chi-square test, and then by multivariate regression analysis for detecting the independent predictor. The main study endpoints were locoregional control (LRC) and disease specific survival (DSS), and the survival time was calculated from date of surgery to the date of an event or latest follow-up. The Kaplan-Meier approach (log-rank test) was used to calculate the LRC and DSS rates. The factors which were significant in univariate analysis were then analyzed in the multivariate proportional hazard Cox model for determining the independent prognostic factors. All statistical analyses were performed on SPSS 20.0, and a *p* \< 0.05 was considered significant.

Results {#s3}
=======

There were 317 patients (227 male and 90 female) enrolled in total, the mean age was 58.3 (range: 28--78) years. Smoker and drinker were noted in 189 (59.6%) and 130 (41.0%) patients, respectively. Clinical tumor stages were distributed as T1 in 143 (45.1%) patients and T2 in 174 (54.9%) patients, respectively. Perineural invasion and lymphovascular invasion were noted in 46 (14.5%) and 33 (10.4%) patients, respectively. Pathologic tumor grade was distributed as well in 122 (38.4%) patients, moderate in 143 (45.1%) patients, and poor in 52 (16.4%) patients. The mean pathologic DOI was 6.9 (range: 3.0--15.8) mm. Negative margin was achieved in all patients (100%). There were 65 (20.5%) patients underwent flap reconstruction for tongue restoration including 25 platysma myocutaneous flaps, 17 submental island flaps, 15 radial forearm flaps, and eight anterolateral thigh flaps.

LLNs were reported in 89 (28.1%) patients, the mean number of LLNs was 1.4 (range: 1--3), 43 of the 89 patients had pathologic LLN metastasis, the mean number of positive LLNs was 1.3 (range: 1--3), the overall LLN metastasis rate was 13.6% (43/317). As described by [Table 1](#T1){ref-type="table"}, the LLN metastasis was significantly associated with cervical lymph node metastasis and tumor stage.

###### 

Association between clinical pathologic variables and lingual lymph node metastasis.

  **Variables**                          **Lingual lymph node status**   ***p***   
  -------------------------------------- ------------------------------- --------- -------
  Age                                                                              
    \<40                                 7                               23        
    ≥40                                  36                              251       0.101
  Sex                                                                              
    Male                                 33                              194       
    Female                               10                              80        0.422
  Smoking                                                                          
    Yes                                  23                              166       
    No                                   20                              108       0.378
  Drinking                                                                         
    Yes                                  15                              115       
    No                                   28                              159       0.380
  Tumor stage                                                                      
    T1                                   12                              131       
    T2                                   31                              143       0.015
  DOI[^\*^](#TN1){ref-type="table-fn"}                                             
    \<5 mm                               15                              132       
    ≥5 mm                                28                              142       0.104
  PI[^\#^](#TN2){ref-type="table-fn"}                                              
    Yes                                  8                               38        
    No                                   35                              236       0.412
  LVI[^%^](#TN3){ref-type="table-fn"}                                              
    Yes                                  5                               28        
    No                                   38                              246       0.779
  Occult metastasis                                                                
    Negative                             23                              206       
    Positive                             20                              68        0.003
  Tumor grade                                                                      
    Well                                 13                              109       
    Moderate                             20                              123       
    Poor                                 10                              42        0.313

*depth of invasion*;

*perineural invasion*;

*lymphovascular invasion*.

Occult neck lymph node metastasis occurred in 88 (27.8%) patients. There was no extracapsular spread. Seventy-eight patients had isolate level I metastasis, nine patients had simultaneous level I and II metastasis, and 1 patient had simultaneous level I, II, and III metastasis. In 43 patients with positive LLNs, 20 patients had occult metastasis, in 46 patients with negative LLNs, 12 patients had occult metastasis, in 228 patients with no LLNs, 56 patients had occult metastasis, the difference was significant (*p* = 0.012). The sensitivity of positive LLN to predict positive occult neck node metastasis was 22.7% (95% CI, 14.5--32.9%), and the positive test likelihood ratio was 2.3 (95% CI, 1.3--3.9). The Chi-square test also reported the significant association between occult metastasis and tumor stage, pathologic DOI, and pathologic tumor grade (all *p* \< 0.05). Further multivariate regression described the factors of tumor stage (*p* = 0.005, 2.445\[1.247--6.332\]), pathologic DOI (*p* = 0.033, 2.118\[1.684--5.226\]), LLN status (*p* = 0.041, 1.984\[1.247--3.222\]), and pathologic tumor grade (*p* = 0.008, 3.221\[1.647--7.669\]) independently increased the risk of occult neck lymph node metastasis ([Table 2](#T2){ref-type="table"}).

###### 

Association between clinical pathologic variables and occult neck lymph node metastasis.

  **Variables**                          **Occult metastasis**   **X^**2**^**   **Multivariate regression**           
  -------------------------------------- ----------------------- -------------- ----------------------------- ------- -----------------------
  Age                                                                                                                 
    \<40                                 7                       23                                                   
    ≥40                                  81                      206            0.569                                 
  Sex                                                                                                                 
    Male                                 63                      164                                                  
    Female                               25                      65             0.996                                 
  Smoking                                                                                                             
    Yes                                  53                      136                                                  
    No                                   35                      93             0.107                                 
  Drinking                                                                                                            
    Yes                                  35                      95                                                   
    No                                   53                      134            0.781                                 
  Tumor stage                                                                                                         
    T1                                   25                      118                                                  
    T2                                   63                      111            \<0.001                       0.005   2.445\[1.247--6.332\]
  DOI[^\*^](#TN4){ref-type="table-fn"}                                                                                
    \<5 mm                               32                      115                                                  
    ≥5 mm                                56                      114            0.027                         0.033   2.118\[1.684--5.226\]
  PI[^\#^](#TN5){ref-type="table-fn"}                                                                                 
    Yes                                  15                      31                                                   
    No                                   73                      198            0.427                                 
  LVI[^%^](#TN6){ref-type="table-fn"}                                                                                 
    Yes                                  13                      20                                                   
    No                                   75                      209            0.115                                 
  LLN[^&^](#TN7){ref-type="table-fn"}                                                                                 
    No                                   56                      172                                                  
    Negative                             12                      34                                                   
    Positive                             20                      23             0.012                         0.041   1.984\[1.247--3.222\]
  Tumor grade                                                                                                         
    Well                                 26                      96                                                   
    Moderate                             40                      103                                                  
    Poor                                 22                      30             0.018                         0.008   3.221\[1.647--7.669\]

*depth of invasion*;

*perineural invasion*;

*lymphovascular invasion*;

*lingual lymph node*.

[Table 3](#T3){ref-type="table"} analyzed the cervical metastasis pattern according to the status of the LLNs, and it described that there might be a trending of more extensive metastasis if there was LLN metastasis.

###### 

Cervical metastasis pattern according to the status of lingual lymph node (LLN) status.

  **Level metastasis**   **LLN status**        
  ---------------------- ---------------- ---- ----
  I                      20               12   56
  II                     2                2    6
  III                    1                0    0

After follow-up with mean time of 37.5 (range: 2--93) months, 100 patients received adjuvant radiotherapy, and 10 patients also received adjuvant chemotherapy, locoregional recurrence occurred in 58 patients, disease-specific death occurred in 43 patients.

The 5-year LRC rate was 77%. In patients without LLNs, the 5-year LRC rate was 79%, in patients with negative LLNs, the 5-year LRC rate was 78%, in patients with positive LLNs, the 5-year LRC rate was 62%, the difference was significant (*p* = 0.024, [Figure 2](#F2){ref-type="fig"}). As described by [Table 4](#T4){ref-type="table"}, the factors of tumor stage, LLN status, neck lymph node metastasis, perineural invasion, lymphovascular invasion, and pathologic DOI were associated with the locoregional control, further Cox model confirmed the independence of LLN status, neck lymph node metastasis, perineural invasion, and pathologic DOI in predicting the LRC survival.

![Comparison of locoregional control survival in patients with different lingual lymph node status (*p* = 0.024).](fonc-10-00471-g0002){#F2}

###### 

Prognostic factors for the locoregional control in patients with cT1-2N0 tongue squamous cell carcinoma.

  **Variables**                 **Univariate analysis**   **Cox model**   
  ----------------------------- ------------------------- --------------- ------------------------
  Age (\<40 vs. ≥40)            0.547                                     
  Sex                           0.336                                     
  Smoking                       0.147                                     
  Drinking                      0.225                                     
  Tumor stage (T1 vs. T2)       0.005                     0.174           3.664\[0.786--12.004\]
  Neck node stage (N0 vs. N+)   0.001                     \<0.001         4.222\[1.782--9.664\]
  DOI\* (\<5 vs. ≥5 mm)         0.026                     0.013           2.643\[1.844--6.449\]
  Perineural invasion           0.014                     0.008           2.847\[1.471--7.552\]
  Lymphovascular invasion       0.008                     0.085           3.412\[0.925--9.227\]
  Pathologic tumor grade        0.111                                     
    Well                                                                  
    Moderate                                                              
    Poor                                                                  
  LLN status                    0.024                                     
    No                                                                    
    Negative                                              0.845           1.235\[0.158--2.111\]
    Positive                                              0.015           1.999\[1.325--4.668\]
  Adjuvant treatment            0.521                                     

The 5-year DSS rate was 78%. In patients without LLNs, the 5-year DSS rate was 84%, in patients with negative LLNs, the 5-year DSS rate was 74%, in patients with positive LLNs, the 5-year DSS rate was 51%, the difference was significant (*p* \< 0.001, [Figure 3](#F3){ref-type="fig"}). As described by [Table 5](#T5){ref-type="table"}, the factors of LLN status, lymphovascular invasion, neck lymph node metastasis, pathologic tumor grade, and pathologic DOI were associated with the DSS, further Cox model confirmed the independence of LLN status, neck lymph node metastasis, pathologic tumor grade, and pathologic DOI in predicting the DSS.

![Comparison of disease specific survival in patients with different lingual lymph node status (*p* \< 0.001).](fonc-10-00471-g0003){#F3}

###### 

Prognostic factors for the disease specific survival in patients with cT1-2N0 tongue squamous cell carcinoma.

  **Variables**                 **Univariate analysis**   **Cox model**   
  ----------------------------- ------------------------- --------------- -----------------------
  Age (\<40 vs. ≥40)            0.254                                     
  Sex                           0.631                                     
  Smoking                       0.215                                     
  Drinking                      0.334                                     
  Tumor stage (T1 vs. T2)       0.088                                     
  Neck node stage (N0 vs. N+)   0.002                     \<0.001         2.222\[1.258--5.331\]
  DOI\* (\<5 vs. ≥5 mm)         0.015                     0.003           3.524\[1.631--8.552\]
  Perineural invasion           0.263                                     
  Lymphovascular invasion       0.014                     0.005           2.338\[1.726--5.434\]
  Pathologic tumor grade        0.021                                     
    Well                                                                  
    Moderate                                              0.015           2.114\[1.235--4.002\]
    Poor                                                  \<0.001         4.669\[1.978--9.224\]
  LLN status                    \<0.001                                   
    No                                                                    
    Negative                                              0.098           1.735\[0.896--3.425\]
    Positive                                              \<0.001         1.845\[1.137--3.987\]
  Adjuvant treatment            0.521                                     

Discussion {#s4}
==========

The most important finding in current study was that the LLN metastasis was significantly associated with the risk of occult metastasis as well as the prognosis in early stage tongue SCC. It could provide benefit in decision making regarding neck management in cT1-2N0 tongue SCC, and also it suggested more advanced treatment would be required in despite of the neck lymph node status.

The presence of neck lymph node metastasis was an important prognostic factor for head and neck SCC ([@B1]--[@B3]). END was usually an important part in primary operation, but owing to the wide range of occult metastasis rate in cT1-2N0 tongue SCC ([@B10]), the neck management of cT1-2N0 tongue SCC has been debated over the years remaining its controversy. Although there was high quality literature including D\'Cruz et al. ([@B26]) and Ren et al. ([@B27]) showed the benefit associated with routine neck dissection, the ideal treatment for patients with cT1-2N0 tongue SCC must be balanced between and the possible surgical morbidity and optimal oncological outcomes. The common principle was that N0 necks should be treated electively when the occult metastatic rate was more than 20% ([@B28]). In current study, the overall occult metastasis rate was 27.8%, but the occult metastasis rate was just 17.5% for T1 disease, all patients underwent END. Therefore, there was a number of patients were over-treated, there were at least three aspects for explaining this phenomenon: firstly, the high requirement of routine follow-up of wait-and-see policy was usually out of our patients\' ability, as described by our previous studies ([@B13], [@B25]), patients in our cancer hospital usually came from low income family and remote districts; secondly, there was abundant evidence indicating that there was often a low salvage rate on disease recurrence in patients who do not have prophylactic therapy of the clinically N0 neck ([@B1]--[@B5]), thirdly, also the most important one, there were no reliable predictors for occult neck lymph node metastasis from previous studies.

A number of researchers had aimed to explore the potential predictors for the occult neck lymph node metastasis. Tumor budding was defined as the presence of small clusters of cancer cells or isolated single cancer cell, it suggested a more aggressive biologic behavior and carried more possibility of migrating to the adjacent stroma. Xie et al. ([@B29]) described the tumor budding intensity was significantly associated with occult lymph node metastasis. Systemic inflammatory response could promote tumor cell proliferation, microvascular regeneration, and tumor metastasis, further, the peripheral neutrophil-to-lymphocyte ratio (NLR) was an accurate and reliable inflammatory marker. High NLR is thought to be significantly associated with worse survival in solid cancers ([@B28]). Abbate et al. ([@B30]) firstly presented there was higher risk for occult neck lymph node metastasis when pre-treatment NLR was greater than 2.93. Loganathan et al. ([@B31]) recently reported END should be considered when the tumor thickness exceeds 5 mm based on the significant relationship between tumor thickness and occult neck lymph node metastasis. Other analyzed variables included perineural invasion, lymphovascular invasion, and pathologic DOI ([@B32], [@B33]). However, data regarding the these pathologic factors usually could not be obtained preoperatively or during operation, and pretreatment NLR were nonspecific parameters because they could be influenced by concomitant conditions, such as infections or inflammation. Therefore, more accurate indicators were needed. In current study it was noted that LLN metastasis was related to additional nearly 2-fold risk of occult metastasis, and might promote more extensive metastasis. The status of LLNs was easily obtained by frozen section, it might act as a useful indicator for END in early stage tongue SCC. LLNs were not included in any N groups in TNM stage system, the lymph pathway draining to the LLNs passes through the medial side of the submandibular gland parahyoid area and connects to the middle internal jugular lymph nodes ([@B13], [@B19]). Saito et al. ([@B19]) firstly described the feasibility of LLN acting as the sentinel lymph node in tongue SCC by imaging methods, current study would support this comment. However, we must considered the fact that the sensitivity and positive test likelihood ratio of positive LLN to predict occult metastasis was a little poor, it was insufficient for deciding neck management, we should not rely solely on the LLN positivity to justify the neck lymph node dissection, more other parameters were needed to increase its reliability.

Prognostic factors for tongue SCC were extensively analyzed, common predictors for worse prognosis included high tumor stage, poor pathologic tumor grade, perineural invasion, lymphovascular invasion, high pathologic DOI, neck lymph node metastasis, high NLR, and so on ([@B2], [@B3], [@B13], [@B14]). But the significance of LLN metastasis was rarely assessed. Jia et al. ([@B14]) recently reported all the patients with LLN metastases had an advanced neck lymph node classification in their 111 patients, the incidence and metastasis of the LLNs were associated with pathological classifications of SCC of the tongue and the floor of the mouth. Similar finding was also noted in a prospective study by Fang et al. ([@B13]), the authors also described LLN metastasis was uncommon, but it could decreased the LRC in advanced tongue SCC. But whether there was similar phenomenon in early stage tongue SCC remained unclear. We were the first to present LLN metastasis significantly decreased the LRC and DSS. In a letter to the editors, Calabrese et al. ([@B34]) stated that LLN metastasis could worsen the prognosis and may act as the same way as level I lymph node metastasis. Our findings may support this hypothesis; however, we do not have such data, more studies were needed to clarify this question.

There are some limitations in current study: firstly, the statistical power was reduced by our relatively small sample size. Secondly, there might be more interesting findings found in the future if the follow-up time was longer. Thirdly, lingual lymph nodes were partially dissected by surgeons, and because of our subjective knowledge, there might be bias for detecting the LLNs ([@B35]).

Conclusions {#s5}
===========

In summary, LLN metastasis is relatively uncommon in early stage tongue SCC, but it is significant associated with the occurrence of occult neck lymph node metastasis, and it apparently decrease the LRC and DSS.
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